These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 34679455)

  • 1. Performance of a Surrogate SARS-CoV-2-Neutralizing Antibody Assay in Natural Infection and Vaccination Samples.
    Chan KH; Leung KY; Zhang RR; Liu D; Fan Y; Chen H; Yuen KY; Hung IF
    Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic Value of a SARS-CoV-2 Rapid Test Kit for Detection of Neutralizing Antibodies as a Point-of-Care Surveillance Test.
    Chan MMH; Leung KY; Zhang RRQ; Liu D; Fan Y; Khong MKW; Tam AR; Chen H; Yuen KY; Hung IFN; Chan KH
    Microbiol Spectr; 2022 Apr; 10(2):e0099321. PubMed ID: 35254121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TOP-Plus Is a Versatile Biosensor Platform for Monitoring SARS-CoV-2 Antibody Durability.
    Racine-Brzostek SE; Karbaschi M; Gaebler C; Klasse PJ; Yee J; Caskey M; Yang HS; Hao Y; Sukhu A; Rand S; Chadburn A; Shi Y; Zuk R; Nussenzweig MC; Cushing MM; Zhao Z
    Clin Chem; 2021 Sep; 67(9):1249-1258. PubMed ID: 33914041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
    Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
    Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 Serology Status Detected by Commercialized Platforms Distinguishes Previous Infection and Vaccination Adaptive Immune Responses.
    Suhandynata RT; Bevins NJ; Tran JT; Huang D; Hoffman MA; Lund K; Kelner MJ; McLawhon RW; Gonias SL; Nemazee D; Fitzgerald RL
    J Appl Lab Med; 2021 Sep; 6(5):1109-1122. PubMed ID: 34170314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Serum Neutralization Assay: A Traditional Tool for a Brand-New Virus.
    Matusali G; Colavita F; Lapa D; Meschi S; Bordi L; Piselli P; Gagliardini R; Corpolongo A; Nicastri E; Antinori A; Ippolito G; Capobianchi MR; Castilletti C; Inmi Covid-Laboratory Team
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33920222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARS-CoV-2 Antibody Neutralization Assay Platforms Based on Epitopes Sources: Live Virus, Pseudovirus, and Recombinant S Glycoprotein RBD.
    Septisetyani EP; Prasetyaningrum PW; Anam K; Santoso A
    Immune Netw; 2021 Dec; 21(6):e39. PubMed ID: 35036026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of a commercially-available surrogate virus neutralization test for severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    Valcourt EJ; Manguiat K; Robinson A; Chen JC; Dimitrova K; Philipson C; Lamoureux L; McLachlan E; Schiffman Z; Drebot MA; Wood H
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115294. PubMed ID: 33387896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern.
    Deshpande A; Harris BD; Martinez-Sobrido L; Kobie JJ; Walter MR
    Front Immunol; 2021; 12():691715. PubMed ID: 34149735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance Evaluation of the BZ COVID-19 Neutralizing Antibody Test for the Culture-Free and Rapid Detection of SARS-CoV-2 Neutralizing Antibodies.
    Jung BK; Yoon J; Bae JY; Kim J; Park MS; Lee SY; Lim CS
    Diagnostics (Basel); 2021 Nov; 11(12):. PubMed ID: 34943430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Track-etched membrane microplate and smartphone immunosensing for SARS-CoV-2 neutralizing antibody.
    Wang C; Wu Z; Liu B; Zhang P; Lu J; Li J; Zou P; Li T; Fu Y; Chen R; Zhang L; Fu Q; Li C
    Biosens Bioelectron; 2021 Nov; 192():113550. PubMed ID: 34391066
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Two Rapid Lateral Flow Tests and Two Surrogate ELISAs for the Detection of SARS-CoV-2 Specific Neutralizing Antibodies.
    Girl P; Zwirglmaier K; von Buttlar H; Wölfel R; Müller K
    Front Med (Lausanne); 2022; 9():820151. PubMed ID: 35187003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with mortality in COVID-19 patients.
    Yang HS; Racine-Brzostek SE; Karbaschi M; Yee J; Dillard A; Steel PAD; Lee WS; McDonough KA; Qiu Y; Ketas TJ; Francomano E; Klasse PJ; Hatem L; Westblade LF; Wu H; Chen H; Zuk R; Tan H; Girardin R; Dupuis AP; Payne AF; Moore JP; Cushing MM; Chadburn A; Zhao Z
    medRxiv; 2020 Nov; ():. PubMed ID: 33236020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation and clinical evaluation of a SARS-CoV-2 surrogate virus neutralisation test (sVNT).
    Meyer B; Reimerink J; Torriani G; Brouwer F; Godeke GJ; Yerly S; Hoogerwerf M; Vuilleumier N; Kaiser L; Eckerle I; Reusken C
    Emerg Microbes Infect; 2020 Dec; 9(1):2394-2403. PubMed ID: 33043818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid Quantification of SARS-CoV-2-Neutralizing Antibodies Using Propagation-Defective Vesicular Stomatitis Virus Pseudotypes.
    Zettl F; Meister TL; Vollmer T; Fischer B; Steinmann J; Krawczyk A; V'kovski P; Todt D; Steinmann E; Pfaender S; Zimmer G
    Vaccines (Basel); 2020 Jul; 8(3):. PubMed ID: 32679691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected Patients.
    Walker SN; Chokkalingam N; Reuschel EL; Purwar M; Xu Z; Gary EN; Kim KY; Helble M; Schultheis K; Walters J; Ramos S; Muthumani K; Smith TRF; Broderick KE; Tebas P; Patel A; Weiner DB; Kulp DW
    J Clin Microbiol; 2020 Oct; 58(11):. PubMed ID: 32855181
    [No Abstract]   [Full Text] [Related]  

  • 17. Performance comparison of micro-neutralization assays based on surrogate SARS-CoV-2 and WT SARS-CoV-2 in assessing virus-neutralizing capacity of anti-SARS-CoV-2 antibodies.
    Sekirov I; Petric M; Carruthers E; Lawrence D; Pidduck T; Kustra J; Laley J; Lee MK; Chahil N; Mak A; Levett PN; Mendoza E; Wood H; Drebot M; Krajden M; Morshed M
    Access Microbiol; 2021; 3(8):000257. PubMed ID: 34888485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemiluminescence Immunoassay Based Serological Immunoassays for Detection of SARS-CoV-2 Neutralizing Antibodies in COVID-19 Convalescent Patients and Vaccinated Population.
    Yin Q; Zhang Y; Lian L; Qu Y; Wu W; Chen Z; Pei R; Chen T; Sun L; Li C; Li A; Li J; Li D; Wang S; Guan W; Liang M
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct capture of neutralized RBD enables rapid point-of-care assessment of SARS-CoV-2 neutralizing antibody titer.
    Connelly GG; Kirkland OO; Bohannon S; Lim DC; Wilson RM; Richards EJ; Tay DM; Jee H; Hellinger RD; Hoang NK; Hao L; Chhabra A; Martin-Alonso C; Tan EKW; Koehler AN; Yaffe MB; London WB; Lee PY; Krammer F; Bohannon RC; Bhatia SN; Sikes HD; Li H
    Cell Rep Methods; 2022 Aug; 2(8):100273. PubMed ID: 35942328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A New SARS-CoV-2 Dual-Purpose Serology Test: Highly Accurate Infection Tracing and Neutralizing Antibody Response Detection.
    Taylor SC; Hurst B; Charlton CL; Bailey A; Kanji JN; McCarthy MK; Morrison TE; Huey L; Annen K; DomBourian MG; Knight V
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33500361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.